Why GLP-1 prices move: teaser rates, step-ups, and supply

The price you see on a GLP-1 provider's homepage is rarely the price you'll pay six months in. That's not always a scam — the market genuinely moves — but a lot of the movement is engineered, and once you can see the mechanics, the offers get much easier to read. This is the editorial backbone of the Dose Brief tracker: watching how these prices actually behave over time.

The teaser rate

The most common pricing move is the teaser: a low first-month price designed to win the sign-up. It works because the moment you're on the medication is the moment you're least likely to shop around. There's nothing illegal about an intro rate — but a headline number that only applies to month one tells you almost nothing about what the program costs to stay on. The first question to ask any provider is simple: what do I pay in month two, and every month after?

The teaser has an honest form and a dishonest one, and August 2026 gave us a clean example of each. The Edit advertises $109 semaglutide and charges $209 from month two — the discount is real, disclosed as a $100-off first order, and printed beside the standing rate, which is about as fair as an intro rate gets. At the other end, Lighter You leads with "start for just $99" and sells nothing at $99; the cheapest figure anywhere on its site is $145, and its catalog sits behind a login, so the headline is not a first month at all. It is not attached to anything. In between sits the form that is easiest to miss because the page is otherwise honest: System Labs prints "$99" in large type with "/first mo." beside it and $179 struck through, and its own FAQ commits to the standing rate in plain words — "billed at a flat $179/mo with no hidden fees". The ongoing number is there to be found; it is simply not the one your eye lands on.

The step-up

Closely related is the step-up: pricing that rises after an introductory window, or as you titrate to a higher dose. Some step-ups are disclosed clearly; others are buried. A desk that charges more for a higher dose should say so up front, and a desk that resets your rate after three months should say that too. When we score price stability, a provider that holds one flat rate through dose changes ranks above one whose line drifts upward — that's the whole point of tracking prices over time rather than snapshotting them once.

There's a quieter version of the same thing that isn't a rate change at all — it's a calendar change. Vyvron bills every four weeks while printing its price with a "/mo" on it, which produces thirteen charges in a year rather than twelve. Nothing about the rate moves; the year just gets an extra one in it. Whenever a price is quoted per month, it's worth checking that the billing cycle is a month.

The stacked fee

Watch for costs that live outside the medication price: a membership fee, a consultation charge, a coaching subscription you can't unbundle, or shipping that isn't included. The advertised number can look great while the all-in monthly cost tells a different story. When you compare two providers, compare the total you'll actually be charged, not the two homepage stickers. Compounded semaglutide is where this behavior shows up most, which is why we track it on its own on the compounded semaglutide ranking.

Supply, the invisible hand

Underneath all of this sits supply. When a molecule is hard to get, prices firm up and discounts vanish; when supply loosens and new desks pile in, competition drives prices down — until a regulatory shift tightens things again. The GLP-1 market has been through exactly this cycle, tied closely to the FDA drug-shortage list and the rules around compounding during a shortage¹². If you want that story in full, read GLP-1 shortages and supply. The takeaway for pricing: a rock-bottom rate that depends on loose supply is not a rate you can count on — and it's also why an unapproved, uncompoundable drug like retatrutide showing up for sale at any price is a red flag rather than a preview discount.

How to read a price like a tracker

Put it together into a habit. Find the ongoing monthly price, not the intro price. Add in every fee. Ask what happens at a higher dose. And weigh the number against how stable it's likely to be — a slightly higher price that holds can beat a cheaper one that resets. The trap that catches the most readers is a headline that was never a monthly rate at all: MyDrHank advertises "from $240/mo" tirzepatide because its price display picks the cheapest rung on a term ladder, and that rung is $2,883 paid twelve months up front — the month-to-month figure is $349 and appears on no page of the funnel. The inverse of that trap is rarer and worth knowing: Bodybuilding Health+ charges more per month the longer you commit on tirzepatide — $209 month-to-month against $286, $250 and $244 on its three-, six- and twelve-month bundles — while badging each of those tiers "Save $X". A commitment discount is a convention, not a law, and the only way to know a given desk follows it is to read every rung. And the same page can pull the trick more than once: on the plan page Try Ageless sends our readers to, the hero's "$159/mo from" and both entry-price cards are twelve-month rungs, billed as $1,908, $2,388 and $2,988 in a single payment, while the month-to-month rates in the table underneath are $199, $279 and $349. When the headline is smaller than every number in the table below it, the table is the honest one. In our ranking we tag each provider's price direction (stable, rising, or falling) for this reason; you can see it in the provider briefs, and stability is one of the six factors behind the Brief Score. If tirzepatide specifically is what you're tracking, our tirzepatide price wire applies this same read to that molecule alone. All pricing figures we cite reflect each provider's published pricing at our last review (August 2026), not a fixed guarantee.

The bottom line

GLP-1 prices move because providers design them to and because supply forces them to. Neither is a reason to panic — it's a reason to read the fine print and favor desks that make their pricing boring and predictable. Start with the 5-minute provider checklist, and if a compounded price looks too good to be true, sanity-check the provider with is compounded semaglutide legit?. This is buyer's guidance, not medical advice.